AsianInvesterAsianInvesterAsianInvester

EMs and Japan top GMO’s seven-year outlook

Jame DiBiasio
The S&P500 is expected to flatline, and China is “California on steroids”, says Edward Chancellor at GMO.
EMs and Japan top GMO’s seven-year outlook

Edward Chancellor, Boston-based head of capital markets research and a member of the asset-allocation team at the $106 billion GMO, says the firm’s seven-year forecast has the S&P500 returning essentially zero returns on an annualised basis.

Sign in to read on!
Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to AsianInvestor

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
If you are a senior professional at a large institutional asset owner, such as a sovereign wealth fund or pension fund, please contact [email protected] for further assistance.

Questions?
See here for more information on licences and prices, or contact [email protected]
¬ Haymarket Media Limited. All rights reserved.